|
2023
|
Invention
|
Pyrrolidine derivatives as oxytocin/vasopressin v1a receptors antagonists.
The present invention... |
|
2022
|
Invention
|
Oral formulations of pyrrolidine derivatives.
The present invention relates to solid oral formul... |
|
2021
|
Invention
|
Compositions and methods for the treatment or prevention of preterm labor. The disclosure provide... |
|
|
Invention
|
Biomarkers for oxytocin receptor antagonist therapy.
The disclosure provides compositions and me... |
|
|
Invention
|
Biomarkers for oxytocin receptor antagonist therapy. The disclosure provides compositions and met... |
|
2020
|
Invention
|
Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage.... |
|
|
Invention
|
Compositions and methods for the treatment of estrogen-dependent disorders. The present disclosur... |
|
|
Invention
|
Gnrh antagonists for the treatment of estrogen-dependent disorders. The present disclosure provid... |
|
|
Invention
|
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists. The present invention ... |
|
2019
|
Invention
|
Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis. The pre... |
|
|
G/S
|
Medical preparations for the prevention and treatment of reproductive and neuropsychiatric diseas... |
|
|
G/S
|
Medical preparations; pharmaceutical and veterinary
products; sanitary preparations for medical ... |
|
|
Invention
|
Oral formulations of pyrrolidine derivatives. The present invention relates to solid oral formula... |
|
2018
|
G/S
|
Medical preparations for the prevention and treatment of reproductive and neuro-psychiatric disea... |
|
|
Invention
|
Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis. The... |
|
|
Invention
|
Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reduc... |
|
2017
|
Invention
|
Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one ... |
|
|
Invention
|
Pyrrolidine derivatives as oxytocin/vasopressin v1a receptors antagonists. The present invention ... |
|
|
Invention
|
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal pol... |
|
2015
|
Invention
|
Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one ... |
|
2014
|
Invention
|
Pyrrolidine derivatives as oxytocin / vasopressin v1a receptors antagonists. The present inventio... |
|
2013
|
G/S
|
Medical [, ] * and * pharmaceutical, [ and veterinary ] preparations for the prevention and trea... |
|
|
G/S
|
Medical, pharmaceutical, veterinary and sanitary products;
pharmaceutical and biotechnological p... |
